Hanseatic Management Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-1,667
| Closed | -$580K | – | 142 |
|
2023
Q3 | $580K | Buy |
1,667
+1
| +0.1% | +$348 | 1.08% | 27 |
|
2023
Q2 | $586K | Sell |
1,666
-14
| -0.8% | -$4.92K | 1.08% | 27 |
|
2023
Q1 | $529K | Sell |
1,680
-24
| -1% | -$7.56K | 1.19% | 28 |
|
2022
Q4 | $492K | Sell |
1,704
-23
| -1% | -$6.64K | 1.25% | 26 |
|
2022
Q3 | $500K | Sell |
1,727
-38
| -2% | -$11K | 1.35% | 22 |
|
2022
Q2 | $497K | Buy |
+1,765
| New | +$497K | 1.13% | 27 |
|
2020
Q4 | – | Sell |
-365
| Closed | -$99K | – | 214 |
|
2020
Q3 | $99K | Sell |
365
-2,584
| -88% | -$701K | 0.22% | 67 |
|
2020
Q2 | $856K | Buy |
2,949
+2,668
| +949% | +$774K | 0.72% | 49 |
|
2020
Q1 | $67K | Hold |
281
| – | – | 0.07% | 131 |
|
2019
Q4 | $62K | Hold |
281
| – | – | 0.06% | 147 |
|
2019
Q3 | $48K | Hold |
281
| – | – | 0.05% | 134 |
|
2019
Q2 | $52K | Sell |
281
-17
| -6% | -$3.15K | 0.05% | 140 |
|
2019
Q1 | $55K | Hold |
298
| – | – | 0.06% | 140 |
|
2018
Q4 | $49K | Buy |
298
+102
| +52% | +$16.8K | 0.07% | 130 |
|
2018
Q3 | $38K | Hold |
196
| – | – | 0.04% | 196 |
|
2018
Q2 | $33K | Sell |
196
-4,913
| -96% | -$827K | 0.03% | 199 |
|
2018
Q1 | $833K | Buy |
5,109
+17
| +0.3% | +$2.77K | 0.8% | 39 |
|
2017
Q4 | $763K | Buy |
5,092
+419
| +9% | +$62.8K | 0.77% | 45 |
|
2017
Q3 | $710K | Sell |
4,673
-261
| -5% | -$39.7K | 0.81% | 43 |
|
2017
Q2 | $636K | Buy |
+4,934
| New | +$636K | 0.32% | 118 |
|
2015
Q4 | – | Sell |
-6,000
| Closed | -$625K | – | 402 |
|
2015
Q3 | $625K | Buy |
+6,000
| New | +$625K | 0.19% | 161 |
|
2015
Q1 | – | Sell |
-16,849
| Closed | -$2M | – | 387 |
|
2014
Q4 | $2M | Buy |
16,849
+147
| +0.9% | +$17.5K | 1.03% | 26 |
|
2014
Q3 | $1.88M | Buy |
+16,702
| New | +$1.88M | 1% | 25 |
|